HER2 expression in gastric and oesophageal cancer: a meta-analytic review

被引:16
作者
Nagaraja, Vinayak [1 ]
Eslick, Guy D. [1 ]
机构
[1] Sydney Med Sch Nepean, Discipline Surg, Whiteley Martin Res Ctr, Penrith, NSW 2751, Australia
关键词
Human epidermal growth factor receptor 2 (HER2); gastric cancer; esophageal cancer;
D O I
10.3978/j.issn.2078-6891.2014.107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Since the advent and the success of adjuvant medical therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer in the form of trastuzumab there has been increasing interest in the development of similar therapies in other solid organ malignancies including gastric cancer and oesophageal cancer. Over the years, multiple observational studies have been inconsistent. Several meta-analyses have been published looking at the association between HER2 and gastric cancer and oesophageal cancer. This review aims to summarize the meta-analytic evidence for the association between HER2 in gastric and oesophageal cancer. Methods: A systematic search was conducted using MEDLINE, PubMed, EMBASE, Current Contents Connect, Cochrane Library, Google Scholar, Science Direct, and Web of Science. Results: Of the articles selected, only nine studies met full criteria. Six of them reviewed the role of HER2 in gastric cancer and the remaining three reviewed its role in oesophageal cancer. Conclusions: The current evidence regarding the role of HER2 is unclear. However, it clearly plays a key role in the pathogenesis of gastric and oesophageal carcinomas. Targeted therapy towards this subgroup (despite variable frequency and association with survival) would offer a mortality benefit and improve survival.
引用
收藏
页码:143 / 154
页数:12
相关论文
共 30 条
[1]   HER2 Gene Amplification and Protein Expression in Pancreatic Ductal Adenocarcinomas [J].
Aumayr, Klaus ;
Soleiman, Afschin ;
Sahora, Klaus ;
Schindl, Martin ;
Werba, Gregor ;
Schoppmann, Sebastian F. ;
Birner, Peter .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (02) :146-152
[2]  
Bang YJ, 2010, LANCET, V376, P1302
[3]   Systematic Review and Meta-analysis of the Influence of HER2 Expression and Amplification in Operable Oesophageal Cancer [J].
Chan, David S. Y. ;
Twine, Christopher P. ;
Lewis, Wyn G. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (10) :1821-1829
[4]   Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis [J].
Chen, Cheng ;
Yang, Jing-mo ;
Hu, Ting-ting ;
Xu, Ting-juan ;
Yan, Guang ;
Hu, Shi-lian ;
Wei, Wei ;
Xu, Wei-ping .
ARCHIVES OF MEDICAL RESEARCH, 2013, 44 (05) :380-389
[5]   Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer [J].
Chen, Meilan ;
Huang, Jizheng ;
Zhu, Zhenli ;
Zhang, Jun ;
Li, Ke .
BMC CANCER, 2013, 13
[6]   Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review [J].
Chua, Terence C. ;
Merrett, Neil D. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (12) :2845-2856
[7]   Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis [J].
de Graeff, P. ;
Crijns, A. P. G. ;
de Jong, S. ;
Boezen, M. ;
Post, W. J. ;
de Vries, E. G. E. ;
van der Zee, A. G. J. ;
de Bock, G. H. .
BRITISH JOURNAL OF CANCER, 2009, 101 (01) :149-159
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]   HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis [J].
Gowryshankar, Ashwini ;
Nagaraja, Vinayak ;
Eslick, Guy D. .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (01) :25-35
[10]   Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis [J].
Gu, Jianchun ;
Zheng, Leizhen ;
Wang, Yajie ;
Zhu, Meiling ;
Wang, Qin ;
Li, Xiaoping .
TUMOR BIOLOGY, 2014, 35 (06) :5315-5321